AI Orchestrates Protein Design From Scratch
Anthropic is shifting AI from a passive assistant to an autonomous laboratory director.
August 19, 2026
Follow us
latest articles
Discover the newest research about AI innovations in 🧪 Drug Discovery.
Regulators Cut Duplicative Gene Therapy Testing
The FDA is letting drugmakers recycle data from past trials to speed up gene therapies, but this regulatory shortcut places a massive burden of proof on developers.
August 10, 2026
Alnylam bets $2 billion on AI RNA design
A massive new partnership signals that the future of genetic medicine relies on algorithms, not just wet labs.
August 10, 2026
Schrödinger Launches Bunsen AI for Molecular Design
A prominent AI skeptic is now betting on autonomous agents to run complex drug discovery physics.
August 8, 2026
Simulating clinical trials before patients enroll
Pharma is moving from AI-driven drug discovery to AI-driven trial simulation to fix a costly ninety percent failure rate.
August 5, 2026
Pathos AI Bets Big on Clinical Rescue
A young startup is spending hundreds of millions to prove that artificial intelligence can salvage stalled drug pipelines.
August 4, 2026
AI catches clinical trial reporting errors cheaply
A new automated tool exposes how easily human editors miss shifted endpoints in published medical research.
August 3, 2026
Eli Lilly Expands TuneLab to Biologics
Big Pharma is learning that keeping proprietary data locked in a vault is no longer the fastest way to win the drug discovery race.
August 1, 2026
GSK Bets Big on Cellular Foundation Models
Big Pharma is shifting its AI strategy from targeting specific diseases to funding the underlying operating system of human biology.
July 30, 2026
Big Pharma Pools Data for Antibody AI
AI drug discovery models are starving for physical data, forcing fierce competitors to pool their proprietary secrets.
July 25, 2026